Hormone Replacement Therapy
"Hormone Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapeutic use of hormones to alleviate the effects of hormone deficiency.
| Descriptor ID |
D020249
|
| MeSH Number(s) |
E02.319.452
|
| Concept/Terms |
Hormone Replacement Therapy- Hormone Replacement Therapy
- Therapy, Hormone Replacement
- Hormone Replacement Therapies
- Replacement Therapies, Hormone
- Therapies, Hormone Replacement
- Replacement Therapy, Hormone
|
Below are MeSH descriptors whose meaning is more general than "Hormone Replacement Therapy".
Below are MeSH descriptors whose meaning is more specific than "Hormone Replacement Therapy".
This graph shows the total number of publications written about "Hormone Replacement Therapy" by people in this website by year, and whether "Hormone Replacement Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 4 | 1 | 5 |
| 2021 | 0 | 5 | 5 |
| 2022 | 2 | 5 | 7 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 1 | 3 |
| 2026 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hormone Replacement Therapy" by people in Profiles.
-
Hormone replacement before brain death increases organ donation rate after catastrophic brain injury: An EAST multicenter trial. J Trauma Acute Care Surg. 2026 Oct 01; 101(4):619-631.
-
A Phase 2 Study of XP-8121: Once-Weekly Subcutaneous Levothyroxine Sodium for the Treatment of Hypothyroidism in Adults. Thyroid. 2026 08; 36(8):853-861.
-
Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. J Clin Endocrinol Metab. 2026 May 19; 111(6):e1626-e1633.
-
Evaluation of the accuracy and readability of large language model responses on menopause and hormone therapy. Menopause. 2026 May 01; 33(5):515-520.
-
Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):945-952.
-
Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):561-571.
-
Metabolic Effects of Gender-Affirming Hormonal Therapy in Youth. Pediatr Ann. 2025 Oct; 54(10):e355-e360.
-
Shared Decisionmaking in the Treatment of Hypothyroidism. Clin Endocrinol (Oxf). 2025 Jul; 103(1):106-112.
-
Treatment Preferences in Patients With Hypothyroidism. J Clin Endocrinol Metab. 2025 Feb 18; 110(3):887-900.
-
TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort. J Clin Endocrinol Metab. 2024 11 18; 109(12):3065-3075.